Business Wire

MSCI and Burgiss Enter Into Strategic Relationship

Share

MSCI Inc. (NYSE:MSCI), a leading provider of mission critical decision support tools and services for the global investment community, has entered into a strategic relationship with The Burgiss Group, LLC, intended to accelerate and expand the use of data, analytics and other investment decision support tools for investors in private assets around the world. As part of the alliance, MSCI will invest $190 million in Burgiss for a significant minority interest.

Burgiss’ offerings include private asset transparency and performance benchmark tools delivered through a unified portfolio management platform, including leading research-quality performance data covering close to 10,000 private asset funds around the world representing nearly $7 trillion of committed capital in private equity, private real estate, private debt, infrastructure and natural resource funds. Burgiss serves over 1,000 firms in 36 countries and about 300 employees across the U.S., Europe and South Africa. With MSCI’s client base of over 7,500 in more than 85 countries, and its leading position in private real estate data, analytics and research; equity and fixed income indexes; environmental, social and governance (ESG) research and ratings; and portfolio performance and risk analytics, the partnership creates a very powerful combination to expand each party’s current offerings and develop new tools and solutions for investors and managers of private assets and multi-asset class portfolios.

“Private asset investing is on the precipice of a significant transformation. Investors are increasingly looking to private assets to achieve outsized, uncorrelated and differentiated returns. However, the willingness of investors to expand their private asset portfolios will depend on new methods and tools that help them better understand the private asset markets, the characteristics of investments, asset valuations, the impact of leverage and liquidity, and the drivers of performance and risk,” said Henry Fernandez, Chairman & CEO of MSCI.

“Through this strategic relationship, MSCI and Burgiss will drive innovation, development and increased adoption of needed tools and solutions for investors in private assets around the world to help them solve critical investment problems and develop greater understanding of their total portfolios,” added Mr. Fernandez.

“This strategic alliance between Burgiss and MSCI makes perfect sense. For 30 years, Burgiss has focused on building best-of-breed tools for private capital investors. With the rising importance of private markets, our clients have been asking for solutions that span both public and private assets,” said James Kocis, Founder & CEO at Burgiss. “We are excited to partner with MSCI to help develop and drive adoption of tools that meet our clients’ needs.”

MSCI’s investment in Burgiss will not impact MSCI’s adjusted EBITDA and is not expected to have a material impact to adjusted EPS in 2020. It will be accounted for under the equity method, with MSCI’s share of Burgiss’ earnings being recognized in Other Income/Expense, Net.

Davis Polk & Wardwell LLP acted as legal advisers to MSCI.

About MSCI

MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 45 years of expertise in research, data and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process. To learn more, please visit www.msci.com.

About Burgiss

Burgiss is the global provider of investment decision support tools for private capital. Along with deep expertise in performance and risk measurement, our analytics platform and research-quality data help investment teams make better investment decisions. We serve over 1,000 firms in 36 countries, and our data covers nearly $7 trillion in private capital.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond MSCI’s control and that could materially affect actual results, levels of activity, performance or achievements. Other factors that could materially affect actual results, levels of activity, performance or achievements can be found in MSCI’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 filed with the Securities and Exchange Commission (“SEC”) on February 22, 2019 and in quarterly reports on Form 10-Q and current reports on Form 8-K filed or furnished with the SEC. If any of these risks or uncertainties materialize, or if MSCI’s underlying assumptions prove to be incorrect, actual results may vary significantly from what MSCI projected. Any forward-looking statement in this press release reflects MSCI’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MSCI’s operations, results of operations, growth strategy and liquidity. MSCI assumes no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise, except as required by law.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Investor Inquiries
Investor.relations@msci.com
Salli Schwartz +1 212 804 5306

Media Inquiries
PR@msci.com
Sam Wang +1 212 804 5244
Melanie Blanco +1 212 981 1049
Laura Hudson +44 20 7336 9653
Rachel Lai +852 2844 9315

MSCI Global Client Service
EMEA Client Service +44 20 7618.2222
Americas Client Service +1 888 588 4567 (toll free)
Asia Pacific Client Service +852 2844 9333

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FPT Proposes Public-Private Partnership Model to Develop Vietnam’s Digital Healthcare Ecosystem10.6.2025 07:17:00 EEST | Press release

Global IT services provider FPT and Pharma Group jointly hosted the Healthcare Innovation Forum - HIF 2025. The event served as a multi-stakeholder dialogue platform with a spotlight on breakthrough innovations in science, technology, and AI to accelerate healthcare advancements and drive digital transformation in public health services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250609760138/en/ FPT Proposes Public-Private Partnership Model to Develop Vietnam’s Digital Healthcare Ecosystem The Forum was attended by Vietnam Deputy PM H.E. Le Thanh Long, key government officials, and international guests including U.S. Ambassador Marc Knapper, Swiss Ambassador Thomas Gass, former German Vice Chancellor Dr. Philipp Rösler, and representatives from Japan, Singapore, and Harvard Medical School. Vietnam Deputy PM H.E. Le Thanh Long stressed the urgent need to reform healthcare, outlining five strategies: accelerate digitaliza

China’s Center for Drug Evaluation Accepts Merck’s Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell Tumor10.6.2025 07:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) officially accepted the company’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with tenosynovial giant cell tumors (TGCT) requiring systemic treatment. The submission follows the granting of Priority Review to pimicotinib by the CDE in May for the treatment of patients with TGCT who require systemic therapy, which is expected to expedite the review process. Pimicotinib, a potentially best-in-class investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., also has been granted breakthrough therapy designation (BTD) by the NMPA. “With the acceptance of our application for pimicotinib and the initiation of the priority review, we aim to offer patients in China the first approved systemic therapy for TGCT

KuppingerCole Recognizes Regula as One of the Innovation Leaders in Identity Verification10.6.2025 04:00:00 EEST | Press release

Regula, a global developer of forensic devices and identity verification (IDV) solutions, has made its inaugural appearance in the KuppingerCole Leadership Compass for Identity Verification 2025. Mentioned in the Innovation Leaders category, the company is recognized for its 100% in-house R&D, forensic-grade technology, global document coverage, and advanced liveness detection capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250609760424/en/ Regula’s innovative in-house technology powers fast, seamless identity checks—now recognized by KuppingerCole Analysts. Specializing in IDV and cybersecurity industry analysis, KuppingerCole forecasts that the global IDV market will grow from $18.4 billion in 2025 to $50.07 billion by 2030, driven by increasing identity fraud, compliance requirements, user expectations, and technological advancements. As identity verification rapidly shifts toward fully remote and automated e

IFF Appoints Virginia “Gina” Drosos to Board of Directors10.6.2025 00:46:00 EEST | Press release

IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Gina Drosos to its board of directors, effective June 16. Drosos brings more than 30 years of executive leadership experience across the retail, consumer goods, beauty and health care industries. “We are very pleased to welcome Gina to the IFF board,” said Kevin O’Byrne, chair of the board. “Gina brings extensive relevant experience, deep consumer insights and a proven ability to drive innovation and lead with purpose, which aligns with our long-term strategy to deliver sustainable growth and value creation for all stakeholders.” Drosos most recently served as chief executive officer and a director of Signet Jewelers Ltd. (NYSE: SIG)—the world’s largest retailer of diamond jewelry—from August 2017 to November 2024. During her tenure, she led the company through a significant transformation, expanding its digital capabilities and enhancing customer experien

Vantage Data Centers Completes Industry’s First Euro-Based Data Center Asset-Backed Securitization (ABS) with €640M Transaction9.6.2025 19:00:00 EEST | Press release

Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced it has raised €640 million in securitized term notes, marking the first-ever euro-based securitization of data center assets in Continental Europe. The transaction includes an additional €80 million in unfunded Variable Funding Notes. The Class A-2 Notes are rated A-, and the Class B Notes are rated BBB- by Standard & Poor’s and Scope Ratings. This transaction follows Vantage’s success last year with the first-ever EMEA data center ABS completed in British pound sterling. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250609592365/en/ Pictured is BER11, part of Vantage’s first Berlin campus located in Brandenburg Park. The notes will be used to refinance four data centers in Germany, two in Offenbach, Frankfurt, and two in Berlin, all of which are fully leased to hyperscale customers. The refinancing is part of Vantage’s wider

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye